Investors Title (NASDAQ:ITIC) Shares Sold by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. lessened its position in Investors Title (NASDAQ:ITICFree Report) by 2.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,560 shares of the insurance provider’s stock after selling 195 shares during the period. Oppenheimer & Co. Inc.’s holdings in Investors Title were worth $1,722,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Franklin Resources Inc. grew its holdings in Investors Title by 34.9% in the fourth quarter. Franklin Resources Inc. now owns 10,724 shares of the insurance provider’s stock valued at $1,739,000 after purchasing an additional 2,776 shares during the period. Bridge City Capital LLC grew its holdings in Investors Title by 17.9% in the first quarter. Bridge City Capital LLC now owns 1,877 shares of the insurance provider’s stock valued at $306,000 after purchasing an additional 285 shares during the period. BNP Paribas Financial Markets grew its holdings in Investors Title by 36.1% in the first quarter. BNP Paribas Financial Markets now owns 637 shares of the insurance provider’s stock valued at $104,000 after purchasing an additional 169 shares during the period. Empowered Funds LLC grew its holdings in Investors Title by 4.2% in the first quarter. Empowered Funds LLC now owns 4,302 shares of the insurance provider’s stock valued at $702,000 after purchasing an additional 175 shares during the period. Finally, Vanguard Group Inc. grew its holdings in Investors Title by 0.9% in the first quarter. Vanguard Group Inc. now owns 67,743 shares of the insurance provider’s stock valued at $11,055,000 after purchasing an additional 591 shares during the period. Institutional investors and hedge funds own 41.40% of the company’s stock.

Investors Title Stock Up 2.1 %

ITIC opened at $231.44 on Wednesday. Investors Title has a 52-week low of $127.71 and a 52-week high of $231.93. The company has a 50 day moving average of $209.48 and a two-hundred day moving average of $180.24. The company has a market cap of $436.03 million, a P/E ratio of 17.11 and a beta of 0.85.

Investors Title (NASDAQ:ITICGet Free Report) last released its quarterly earnings data on Tuesday, August 6th. The insurance provider reported $4.70 earnings per share (EPS) for the quarter. Investors Title had a net margin of 11.25% and a return on equity of 10.32%. The company had revenue of $65.38 million during the quarter.

Investors Title Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Shareholders of record on Tuesday, September 3rd were paid a dividend of $0.46 per share. The ex-dividend date of this dividend was Tuesday, September 3rd. This represents a $1.84 annualized dividend and a yield of 0.80%. Investors Title’s dividend payout ratio is currently 13.90%.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded shares of Investors Title from a “buy” rating to a “hold” rating in a report on Wednesday, August 7th.

View Our Latest Stock Report on Investors Title

Investors Title Company Profile

(Free Report)

Investors Title Company engages in the issuance of residential and commercial title insurance for residential, institutional, commercial, and industrial properties. The company underwrites land title insurance for owners and mortgagees as a primary insurer; and assumes the reinsurance of title insurance risks from other title insurance companies.

See Also

Want to see what other hedge funds are holding ITIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Investors Title (NASDAQ:ITICFree Report).

Institutional Ownership by Quarter for Investors Title (NASDAQ:ITIC)

Receive News & Ratings for Investors Title Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Investors Title and related companies with MarketBeat.com's FREE daily email newsletter.